ImmunityBio, Inc. (IBRX)

ImmunityBio Revenue

In the year 2023, ImmunityBio had annual revenue of $622.00K with 159.17% growth. Revenue in the quarter ending December 31, 2023 was $139.00K with 90.41% year-over-year growth.

• Revenue (ttm): $622.00K
• Revenue Growth: +159.17%
• P/S Ratio: 9,740.88
• Revenue / Employee: $990
• Employees: 628
• Market Cap: 6.06B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	622.00K	382.00K	159.17%
Dec 31, 2022	240.00K	-694.00K	-74.30%
Dec 31, 2021	934.00K	329.00K	54.38%
Dec 31, 2020	605.00K	-1.60M	-72.52%
Dec 31, 2019	2.20M	2.16M	4,585.11%
Dec 31, 2018	47.00K	2.00K	4.44%
Dec 31, 2017	45.00K	1,000.00	2.27%
Dec 31, 2016	44.00K	-192.00K	-81.36%
Dec 31, 2015	236.00K	-405.00K	-63.18%
Dec 31, 2014	641.00K	41.00K	6.83%
Dec 31, 2013	600.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.